Market Tracker

04/28 5:16pm ET

Biogen Inc (NASDAQ:BIIB)

271.21
Delayed Data
As of Apr 28
 -5.36 / -1.94%
Today’s Change
205.42
Today|||52-Week Range
307.33
+3.83%
Year-to-Date
Merger Buzz Drives Akorn to Top of Health Chart in April
Apr 28 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Biogen Gains on Strong Q1, NASH Data on Gilead Drug
Apr 26 / Zacks.com - Paid Partner Content
Acorda (ACOR) Q1 Loss Wider Than Expected, Revenues Miss
Apr 28 / Zacks.com - Paid Partner Content
High-Stakes Meeting Between Avexis and FDA Will Set the Course for Gene Therapy and D...
Apr 26 / TheStreet.com - Paid Partner Content
The 4 Principles That Drive PRIMECAP
Apr 27 / GuruFocus News - Paid Partner Content
Nasdaq Tops 6,000 in Busy Day of Milestones for Wall Street
Apr 25 / TheStreet.com - Paid Partner Content
Stock Market News for April 26, 2017
Apr 26 / Zacks.com - Paid Partner Content
First Quadrant L P Buys Williams, LyondellBasell Industries NV, Zoetis, Sells Verizon...
Apr 25 / GuruFocus News - Paid Partner Content
Pharma Stocks Q1 Earnings Roster for Apr 27: CELG, ABBV, BMY
Apr 26 / Zacks.com - Paid Partner Content
Lilly (LLY) Tops Q1 Earnings, Misses Sales, Shares Down
Apr 25 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close276.57
Today’s open277.09
Day’s range271.06 - 277.28
Volume1,803,391
Average volume (3 months)1,656,882
Market cap$57.5B
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+10.32%
Earnings growth (this year)+1.69%
Earnings growth (next 5 years)+5.90%
Revenue growth (last year)+9.37%
P/E ratio16.0
Price/Sales6.09
Price/Book4.82

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc+1.12+0.61%
GILDGilead Sciences-0.03-0.04%
BIVVBioverativ Inc+0.72+1.24%
NBIXNeurocrine Bioscienc...-0.19-0.35%
Data as of 4:14pm ET, 04/28/2017

Financials

Last reporting dateApril 25, 2017
EPS forecast (this quarter)$4.98
Annual revenue (last year)$10.2B
Annual profit (last year)$3.7B
Net profit margin36.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
Cambridge, Massachusetts

Forecasts